Papers

2

Total Citations

28

H-Index

2

About

Dr. Malak Abedalthagafi is a pioneering biomedical researcher whose work sits at the intersection of advanced bioprinting, cancer biology, and rapid diagnostics. Her primary research focuses on developing innovative 3D models of the bone marrow microenvironment to study acute myeloid leukemia (AML). In her highly cited 2023 study, she fabricated a three-dimensional bone marrow niche-like AML disease model using a robotic multicellular bioprinting system, creating a robust platform to investigate drug resistance and disease relapse mechanisms. This work has garnered 15 citations for its potential to transform preclinical leukemia research. Dr. Abedalthagafi has also made significant contributions to pandemic response, developing a lateral flow assay for rapid in-field detection of COVID-19 antibodies using additive manufacturing technologies. Her 2021 paper on this subject, with 13 citations, demonstrates her ability to apply bioprinting expertise to urgent global health challenges. By combining automation, 3D printing, and tissue engineering, Dr. Abedalthagafi is advancing personalized medicine approaches for hematological malignancies while creating scalable diagnostic tools. Her interdisciplinary work bridges bioengineering and clinical oncology, offering new pathways for understanding disease mechanisms and developing targeted therapies.

Research Focus

Key Achievements

2
H-Index
2
Papers
28
Total Citations
14
Avg Citations/Paper
🏆 Most Cited Paper
Fabrication of a three-dimensional bone marrow niche-like acute myeloid Leukemia disease model by an automated and controlled process using a robotic multicellular bioprinting system
15 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 25
🏛 Institutions: Emory University, King Abdulaziz City for Science and Technology

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago